Edition:
United States

Profile: UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

2,140JPY
28 Apr 2016
Change (% chg)

¥-57 (-2.59%)
Prev Close
¥2,197
Open
¥2,190
Day's High
¥2,207
Day's Low
¥2,058
Volume
103,300
Avg. Vol
221,636
52-wk High
¥3,345
52-wk Low
¥1,186

Search Stocks
UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacture and sale of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal influenza vaccine UMN-0502, pandemic influenza vaccine UMN-0501, pandemic influenza vaccine UMN-0901 and norovirus/rotavirus vaccine UMN-2003. As of December 31, 2012, the Company had one consolidated subsidiary.

Company Address

UMN Pharma Inc

26F, Yokohama Landmark Tower
2-2-1, Minato Mirai, Nishi-ku
YOKOHAMA-SHI   KNG   220-8126
P: +8145.2639200
F: +8145.2639205

Company Web Links

Search Stocks